1. Klauser AG et al. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335(8683):205-8. 2. Locke GR 3d et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology 1997;112:1448-56. 3. Heidelbaugh JJ et al. Management of Gastroesophageal Reflux Disease. American Family Physicians Journal 2003 Oct 1; 68:1311-1318 4.Gerson LB et al. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Am J Gastroenterol 2000;95:395-407 5.Raghunath A et al.Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.BMJ 2003 April 5; 326:737-739 6. Harvey RF et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project .BMJ 2004 Jun 12; 328:1417 7. Lagergren J et al. Symtomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340:825-831 8. Gerson LB et al.Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-467 9. Conio M, et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol September 2003;98:1931-9 10. Johansson K et al. Oesophagitis, signs of reflux and acid gastric secretion in patients with symtoms of gastroesophageal reflux disease. Scand J Gastroenterol 1986: 837-847 11. Chiba N et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a metaanalysis. Gatroenterology 1997; 112:1798-1810 12. Spechler SJ. Barrett's esophagus. N Engl J Med 2002 March 14; 346:836-842 13. Inadomi JM et al. Step-down management of gastroesophageal reflux disease. Gastroenterolgy 2001; 121:1095-1100 14. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16:167-180 15. So JB, Zeitels SM et al. Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 1998;124:28-32 16.Spechler SJ et al.Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001;285:2331-8 17.Lundell L et al. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.J Am Coll Surg 2001;192:172-9 18. Lehman GA. Endoscopic and endoluminal techniques for the control of gastroesophageal reflux: are they ready for widespread application? Gastrointest Endosc 2000;52:808-11. 19. Kaltenbach T et al. Are Lifestyle Measures Effective in Patients With Gastroesophageal Reflux Disease? An Evidence-Based Approach. Arch Intern Med. 2006 May 8; 166:965-971. 20. Dominitz JA et al. Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol 2006 Mar; 4:299-305. 21. Macdonald CE et al. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000 Nov 18; 321.1252-1255
|
|
